These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29232800)

  • 1. [A Case of Fulminant Hepatitis after Administration of Abiraterone Acetate].
    Yumiba S; Komori K; Iwanishi T; Koida Y; Kobayashi M; Ono Y
    Hinyokika Kiyo; 2017 Nov; 63(11):479-482. PubMed ID: 29232800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counterpoint: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Abiraterone.
    Jones RJ
    Oncology (Williston Park); 2018 May; 32(5):223, 226-7, 247. PubMed ID: 29847852
    [No Abstract]   [Full Text] [Related]  

  • 3. Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy.
    Isaacsson Velho P; Eisenberger MA
    Oncology (Williston Park); 2018 May; 32(5):223-6. PubMed ID: 29847851
    [No Abstract]   [Full Text] [Related]  

  • 4. Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis.
    Roviello G; Corona SP; Generali D
    Med Oncol; 2017 Aug; 34(10):166. PubMed ID: 28852974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abiraterone acetate and acute leukemia: a casual association?
    Bolzacchini E; Patriarca C; Giordano M
    Anticancer Drugs; 2021 Jan; 32(1):102-104. PubMed ID: 32932280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Delayed Hypersensitivity Reaction to Abiraterone Acetate.
    Lainez-Nuez A; Crespo J; Noguerado-Mellado B; Tejero-Alcalde M; Tornero P; Rojas-Pérez-Ezquerra P
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):168-170. PubMed ID: 32694093
    [No Abstract]   [Full Text] [Related]  

  • 7. Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.
    Sternberg CN; Castellano D; Daugaard G; Géczi L; Hotte SJ; Mainwaring PN; Saad F; Souza C; Tay MH; Garrido JM; Galli L; Londhe A; De Porre P; Goon B; Lee E; McGowan T; Naini V; Todd MB; Molina A; George DJ;
    Lancet Oncol; 2014 Oct; 15(11):1263-8. PubMed ID: 25242048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate.
    Jamani R; Lee EK; Berry SR; Saluja R; DeAngelis C; Giotis A; Emmenegger U
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1391-1399. PubMed ID: 27561266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abiraterone acetate (AA): current guidelines of prescription of abiraterone].
    Boissier E; Loriot Y; Vignot S; Massard C
    Bull Cancer; 2014 Apr; 101(4):388-93. PubMed ID: 24793632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusually high alanine aminotransferase to aspartate aminotransferase ratio in a patient with cyproterone-induced icteric hepatitis.
    Hsu YC; Tai DI
    Chang Gung Med J; 2011; 34(6 Suppl):34-8. PubMed ID: 22490456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-chemotherapy abiraterone acetate. A proposal of a treatment algorithm in castration resistant prostate cancer.
    Arrabal-Martín M; Anglada-Curado F; Cózar-Olmo JM; Soler-Martínez J; Moreno-Jiménez J; Castiñeiras-Fernández J; Ledo-Cepero MJ; Beardo-Villar P; Requena-Tapia MJ; Zuluaga-Gómez A;
    Actas Urol Esp; 2014 Jun; 38(5):327-33. PubMed ID: 24342031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abiraterone acetate: a novel drug for castration-resistant prostate carcinoma.
    Nandha R
    J Postgrad Med; 2012; 58(3):203-6. PubMed ID: 23023354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302.
    Saad F; Shore N; Van Poppel H; Rathkopf DE; Smith MR; de Bono JS; Logothetis CJ; de Souza P; Fizazi K; Mulders PF; Mainwaring P; Hainsworth JD; Beer TM; North S; Fradet Y; Griffin TA; De Porre P; Londhe A; Kheoh T; Small EJ; Scher HI; Molina A; Ryan CJ
    Eur Urol; 2015 Oct; 68(4):570-7. PubMed ID: 25985882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, pharmacodynamics and clinical efficacy of abiraterone acetate for treating metastatic castration-resistant prostate cancer.
    Han CS; Patel R; Kim IY
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):967-75. PubMed ID: 25936418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer.
    Fan L; Wang Y; Chi C; Pan J; Xun S; Xin Z; Hu J; Zhou L; Dong B; Xue W
    BJU Int; 2017 Aug; 120(2):226-232. PubMed ID: 28107595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Free DNA Modification Dynamics in Abiraterone Acetate-Treated Prostate Cancer Patients.
    Gordevičius J; Kriščiūnas A; Groot DE; Yip SM; Susic M; Kwan A; Kustra R; Joshua AM; Chi KN; Petronis A; Oh G
    Clin Cancer Res; 2018 Jul; 24(14):3317-3324. PubMed ID: 29615462
    [No Abstract]   [Full Text] [Related]  

  • 17. Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
    Binder M; Zhang BY; Hillman DW; Kohli R; Kohli T; Lee A; Kohli M
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it possible that one patient may again experience a response to abiraterone acetate withdrawal during an abiraterone acetate rechallenge?
    Maines F; Veccia A; Caffo O
    Eur Urol; 2014 Jul; 66(1):179-80. PubMed ID: 24685435
    [No Abstract]   [Full Text] [Related]  

  • 19. Abiraterone acetate as a possible cause of sudden cardiac death.
    Sahin S; Karatas F; Eren T; Altinbas M; Altundag K
    J BUON; 2016; 21(3):751-2. PubMed ID: 27569102
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.
    Logothetis CJ; Basch E; Molina A; Fizazi K; North SA; Chi KN; Jones RJ; Goodman OB; Mainwaring PN; Sternberg CN; Efstathiou E; Gagnon DD; Rothman M; Hao Y; Liu CS; Kheoh TS; Haqq CM; Scher HI; de Bono JS
    Lancet Oncol; 2012 Dec; 13(12):1210-7. PubMed ID: 23142059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.